Asymmetric U-shaped relationship between blood glucose and white matter lesions: results of a cross-sectional study

Table 2 Relationship between blood glucose and WMLs

Variables Blood glucose	Total (n)	WML n(%)	Model I OR(95% CI)	P-value	Model II OR(95% CI)	P-value	Model III OR(95% CI)	P-value
<95(mg/dl)	457	248 (54.3)	1.31 (1.01–1.69)	0.039	1.47 (1.09-2.00)	0.012	1.49 (1.10-2.00)	0.009
95–100(mg/dl)	494	235 (47.6)	1.00(Ref)		1.00(Ref)		1.00(Ref)
101–107(mg/dl)	434	216 (49.8)	1.09 (0.84–1.41)	0.504	1.03 (0.76–1.39)	0.841	1.00 (0.74–1.36)	0.990
>107(mg/dl)	519	345 (66.5)	2.19 (1.7–2.82)	< 0.001	1.67 (1.24–2.25)	0.001	1.53 (1.10–2.21)	0.011
p for trend			< 0.001		0.316		0.964

Model I, No adjustment. Model II, Adjusted for age and gender. Model III, Adjusted for age, gender, carotid plaque score, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglyceride, ratio of LDL to HDL, body mass index, mean arterial pressure, plaque number, amount of drink, cholesterol-lowering drugs, drink habit, insulin, metabolic syndrome and antihypertensive drugs

ISSN: 1471-2377